Related Experiment Video
Updated: May 2, 2026
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
Antiproliferative effects of protopanaxadiol ginsenosides on human colorectal cancer cells
Yan Zheng1, Hongmei Nan2, Miao Hao3
1China-Japan Union Hospital, Jilin University, Changchun, Jilin 130033, P.R. China.
Abstract:
Ginsenosides are the main biologically active components of ginseng. In this study, seven types of protopanaxadiol ginsenosides were assessed for their antiproliferative activity on the HCT-116 and HT-29 human colorectal cancer cell lines using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The experimental results indicated that the native protopanaxadiol ginsenosides Rb1 and Rb2 inhibited the proliferation of the colorectal cancer cells in a dose-dependent manner. The deglycosylation products F2 and CO (from ginsenosides Rb1 and Rb2, respectively) significantly inhibited the growth of the human colorectal cancer cell lines, whereas product C-K (from Rb1 and Rb2) exerted no antiproliferative effects on the cancer cell lines assessed in this study. HT-29 cells were more sensitive to these ginsenosides compared to HCT-116 cells. In addition, the antiproliferative activity of ginsenosides was found to be correlated with the number and type of sugar residues. The potent growth inhibitory effect of protopanaxadiol ginsenosides on cancer cells may be used in the pharmaceutical industry.
Insights
Protopanaxadiol ginsenosides, like Rb1 and Rb2, show potential in inhibiting colorectal cancer cell growth. Their effectiveness varies based on sugar structure, with some derivatives like F2 and CO proving more potent than C-K.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Oncology
Background:
- Ginsenosides are key bioactive compounds in ginseng.
- Colorectal cancer remains a significant global health concern.
- Understanding the mechanisms of natural compounds against cancer is crucial.
Purpose of the Study:
- To evaluate the antiproliferative effects of seven protopanaxadiol ginsenosides on human colorectal cancer cell lines (HCT-116 and HT-29).
- To investigate the structure-activity relationship of ginsenosides concerning their antiproliferative potency.
- To explore the potential pharmaceutical applications of ginsenosides in cancer therapy.
Main Methods:
- Utilized the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay to assess cell viability.
- Tested native ginsenosides Rb1 and Rb2, and their deglycosylation products F2, CO, and C-K.
- Compared the sensitivity of HCT-116 and HT-29 colorectal cancer cell lines to these compounds.
Main Results:
- Native ginsenosides Rb1 and Rb2 demonstrated dose-dependent inhibition of colorectal cancer cell proliferation.
- Deglycosylation products F2 and CO significantly inhibited cancer cell growth, while C-K showed no effect.
- HT-29 cells exhibited greater sensitivity to the tested ginsenosides than HCT-116 cells.
- Antiproliferative activity correlated with the number and type of sugar residues on the ginsenosides.
Conclusions:
- Protopanaxadiol ginsenosides, particularly F2 and CO, possess significant antiproliferative activity against colorectal cancer cells.
- The structural characteristics, specifically sugar moieties, influence the potency of ginsenosides.
- These findings suggest a promising role for specific ginsenosides in the development of novel colorectal cancer therapeutics.
